CpG oligonucleotides as immune adjuvants.

Suppr

超能文献

作者信息

Krieg A M

机构信息

University of Iowa, Department of Internal Medicine, Iowa City 52242, USA.

出版信息

Ernst Schering Res Found Workshop. 2000(30):105-18. doi: 10.1007/978-3-662-04183-3_7.

DOI:10.1007/978-3-662-04183-3_7

PMID:10943319

Abstract

摘要

相似文献

CpG oligonucleotides as immune adjuvants.

Ernst Schering Res Found Workshop. 2000(30):105-18. doi: 10.1007/978-3-662-04183-3_7.

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.

Biochim Biophys Acta. 1999 Dec 10;1489(1):107-16. doi: 10.1016/s0167-4781(99)00147-5.

Therapeutic applications of CpG-containing oligodeoxynucleotides.

Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4. doi: 10.1089/oli.1.1998.8.181.

Adjuvant activity of CpG oligodeoxynucleotides.

Int Rev Immunol. 2006 May-Aug;25(3-4):135-54. doi: 10.1080/08830180600743057.

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

J Immunol. 1998 Jan 15;160(2):870-6.

The response of human B lymphocytes to oligodeoxynucleotides.

Springer Semin Immunopathol. 2000;22(1-2):63-75. doi: 10.1007/s002810000017.

Immunopharmacology of CpG DNA.

Biol Chem. 2002 Oct;383(10):1491-500. doi: 10.1515/BC.2002.171.

Cytokine gene-engineered vaccines.

Curr Opin Mol Ther. 1999 Feb;1(1):34-8.

CpG motifs for optimization of DNA vaccines.

Dev Biol (Basel). 2000;104:165-9.

Immunostimulatory oligonucleotides: ready for immunotherapy prime time!

J Hematother Stem Cell Res. 2003 Oct;12(5):467-71. doi: 10.1089/152581603322448178.

引用本文的文献

Innovations in oligonucleotide drug delivery.

J Pharm Sci. 2003 Aug;92(8):1559-73. doi: 10.1002/jps.10399.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

CpG oligonucleotides as immune adjuvants.

Ernst Schering Res Found Workshop. 2000(30):105-18. doi: 10.1007/978-3-662-04183-3_7.

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.

Biochim Biophys Acta. 1999 Dec 10;1489(1):107-16. doi: 10.1016/s0167-4781(99)00147-5.

Therapeutic applications of CpG-containing oligodeoxynucleotides.

Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4. doi: 10.1089/oli.1.1998.8.181.

Adjuvant activity of CpG oligodeoxynucleotides.

Int Rev Immunol. 2006 May-Aug;25(3-4):135-54. doi: 10.1080/08830180600743057.

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

J Immunol. 1998 Jan 15;160(2):870-6.

The response of human B lymphocytes to oligodeoxynucleotides.

Springer Semin Immunopathol. 2000;22(1-2):63-75. doi: 10.1007/s002810000017.

Immunopharmacology of CpG DNA.

Biol Chem. 2002 Oct;383(10):1491-500. doi: 10.1515/BC.2002.171.

Cytokine gene-engineered vaccines.

Curr Opin Mol Ther. 1999 Feb;1(1):34-8.

CpG motifs for optimization of DNA vaccines.

Dev Biol (Basel). 2000;104:165-9.

Immunostimulatory oligonucleotides: ready for immunotherapy prime time!

J Hematother Stem Cell Res. 2003 Oct;12(5):467-71. doi: 10.1089/152581603322448178.

引用本文的文献

Innovations in oligonucleotide drug delivery.

J Pharm Sci. 2003 Aug;92(8):1559-73. doi: 10.1002/jps.10399.